Navigating Decentralized Clinical Trials With FDA's Guidance
By Eric Kraus, George Hajduczok and Julia Markov · November 19, 2024, 4:20 PM EST
On Sept. 18, the U.S. Food and Drug Administration issued final guidance titled "Conducting Clinical Trials With Decentralized Elements," for sponsors, investigators and other interested parties to support drug, biologic and...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login